Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (14 August 2026) approved vimseltinib (romvimza) to treat adult patients with tenosynovial…